Coverage / COR / Trade Card

COR

Cencora Inc

BUY Analysis generated 2026-10-04 Market data as of 2026-11-12 Market data 3 days old USD 349.38 Healthcare - Medical - DistributionREDUCE ZONE
ACTIONABLEMethodology gates passed
69

Position levels

Currenttoday
USD 349.38
Buy <=wait / entry
USD 265.00
Trim >=take some off
USD 325.00
Thesis breakA material federal enforcement action under the anti-kickback statute or Drug Su...
-

Scenario-weighted conviction

ProbabilityScoreContribution
Bull case37%100 / 10037.0
Base case50%62 / 10031.0
Bear case13%10 / 1001.3
Weighted conviction69 / 100 - BUY

Top risks

  • Raised full-year adjusted diluted EPS guidance to $17.75-$17.95 for fiscal 2026
  • Q3 fiscal 2026 adjusted diluted EPS of $4.48, beating estimate of $4.35 and up 12% YoY
  • Completed OneOncology acquisition contributing to adjusted operating income growth of 17%
Read full report →

Research is for informational purposes only. Not financial advice. All analysis reflects the date of publication.

\n